BackThird Harmonic Bio Overview

Third Harmonic Bio Gross Profit

Latest gross profit for THRD: $-12K, below the sector sector average of $790M.

Get informed when a big investor buys or sells

+ Follow

Quarterly Gross Profit

N/A

As of Mar 31, 2025

Annual Gross Profit (TTM)

$-12000.00
102.58% YoY

Trailing 12 months ending Mar 31, 2025

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Third Harmonic Bio (THRD) FAQ

Third Harmonic Bio (THRD) currently reports a gross profit of $-12K as of March 2025. That compares with $470K in the prior-year period — down 102.6% year over year. That is below the sector sector average of $790M. Use the charts on this page to explore Third Harmonic Bio's gross profit history and peer comparisons.

Third Harmonic Bio's gross profit decreased from $470K to $-12K — a 102.6% year-over-year decrease (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Third Harmonic Bio's gross profit of $-12K is lower than the its sector sector average of $790M. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Third Harmonic Bio reported $-12K in gross profit as of March 2025. That compares with $470K in the prior-year period — down 102.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current gross profit of $-12K, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $790M. From there, open related valuation or income-statement pages for Third Harmonic Bio, and consider following THRD for alerts when major investors trade the stock.